Symbol="BCLI"
AssetType="Common Stock"
Name="Brainstorm Cell Therapeutics Inc"
Description="Brainstorm Cell Therapeutics Inc., a biotechnology company, is dedicated to the development and commercialization of autologous cell therapies for the treatment of neurodegenerative diseases. The company is headquartered in New York, New York."
CIK="1137883"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="75627000"
EBITDA="-22082000"
PERatio="None"
PEGRatio="0"
BookValue="-0.095"
DividendPerShare="0"
DividendYield="0"
EPS="-0.64"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.131"
ReturnOnEquityTTM="-11.22"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="47.39"
EVToRevenue="-"
EVToEBITDA="-2.429"
Beta="-0.533"
num_52WeekHigh="4.56"
num_52WeekLow="1.085"
num_50DayMovingAverage="1.801"
num_200DayMovingAverage="2.1"
SharesOutstanding="45015800"
DividendDate="None"
ExDividendDate="None"
symbol="BCLI"
open="1.67"
high="1.77"
low="1.67"
price="1.71"
volume="211571.00"
latest_trading_day="2023-08-31"
previous_close="1.68"
change="0.03"
change_percent="1.7857%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="233778"
Change_recent_avg="-0.02"
Delta_recent_avg="0.17"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.91"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="172"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_negative_thumbnail_id_2="109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="644"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
